Xueming Qian

Title: Innovations of Xueming Qian in Estrogen Receptor-Associated Treatments

Introduction

Xueming Qian is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for treating estrogen receptor-associated diseases. His work is crucial in advancing medical treatments that target specific receptor functions.

Latest Patents

Xueming Qian holds a patent for "Antibodies and methods for treating estrogen receptor-associated diseases." This patent includes antibodies, antibody fragments, and pharmaceutical compositions designed to modulate the functions of estrogen receptor alpha 36. The methods outlined in the patent aim to prevent and treat diseases mediated by this receptor, showcasing Qian's innovative approach to addressing complex health issues.

Career Highlights

Qian is affiliated with Beijing Shenogen Pharma Group Ltd., where he applies his expertise in biotechnology and pharmaceuticals. His role at the company allows him to collaborate with other professionals in the field, enhancing the development of effective treatments.

Collaborations

Xueming Qian has worked alongside notable colleagues such as Kun Meng and Feng Chen. Their combined efforts contribute to the advancement of research and development in the pharmaceutical industry.

Conclusion

Xueming Qian's innovative work in the field of antibodies and estrogen receptor-associated diseases highlights his significant impact on medical science. His contributions are paving the way for new treatment options that could improve patient outcomes.